Analysts are focusing on companies with dominant market positions and structural growth tailwinds:
: Remains the UK's most valuable company (£234bn cap). It is favored for its strong oncology and respiratory pipeline and long-term healthcare growth theme.
For investors seeking dividends, the following are frequently cited: